Enterome
Clinical trials sponsored by Enterome, explained in plain language.
-
Experimental vaccine fights rare adrenal cancers
Disease control TerminatedThis study tested a new cancer vaccine called EO2401 combined with an immunotherapy drug for people with advanced adrenal cancers that had spread. The goal was to see if this combination was safe and could help control these rare, aggressive tumors. The trial enrolled 70 adults w…
Phase: PHASE1, PHASE2 • Sponsor: Enterome • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New vaccine strategy aims to stop Cancer's return
Disease control TerminatedThis study tested a new type of vaccine, EO2040, combined with an immunotherapy drug (nivolumab). It aimed to prevent colorectal cancer from returning in patients who had finished standard treatment but still had tiny traces of cancer DNA in their blood. The trial was terminated …
Phase: PHASE2 • Sponsor: Enterome • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC